Skip to content
10-Q

Quarterly Report

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL

0001100682-26-000038

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 24, 2026 48.17M sh
Shares Diluted Q1 2026 · Mar 28, 2026 48.95M sh
Shares Diluted Q1 2026 · Mar 29, 2025 50.85M sh
Stock Repurchased Q1 2026 · Mar 28, 2026 $208.29M
Stock Repurchased Q1 2026 · Mar 29, 2025 $353.13M
Capex Q1 2026 · Mar 28, 2026 $55.91M
Capex Q1 2026 · Mar 29, 2025 $59.32M
Operating Cash Flow Q1 2026 · Mar 28, 2026 $41.08M
Operating Cash Flow Q1 2026 · Mar 29, 2025 $171.7M
Short Term Debt Q1 2026 · Mar 28, 2026 $6.7M
Short Term Debt Q1 2026 · Dec 27, 2025 $166K
Cash And Equivalents Q1 2026 · Mar 28, 2026 $191.83M
Cash And Equivalents Q1 2026 · Dec 27, 2025 $213.77M
Cash And Equivalents Q1 2026 · Mar 29, 2025 $229.36M
Stockholders Equity Q1 2026 · Mar 28, 2026 $2.94B
Stockholders Equity Q1 2026 · Dec 27, 2025 $3.16B
Current Liabilities Q1 2026 · Mar 28, 2026 $1.09B
Current Liabilities Q1 2026 · Dec 27, 2025 $1.12B
Total Liabilities Q1 2026 · Mar 28, 2026 $4.74B
Total Liabilities Q1 2026 · Dec 27, 2025 $3.92B
Current Assets Q1 2026 · Mar 28, 2026 $1.49B
Current Assets Q1 2026 · Dec 27, 2025 $1.45B
Total Assets Q1 2026 · Mar 28, 2026 $7.73B
Total Assets Q1 2026 · Dec 27, 2025 $7.14B
Eps Diluted Q1 2026 · Mar 28, 2026 −$0.30
Eps Diluted Q1 2026 · Mar 29, 2025 $0.50
Eps Basic Q1 2026 · Mar 28, 2026 −$0.30
Eps Basic Q1 2026 · Mar 29, 2025 $0.50
Sga Expense Q1 2026 · Mar 28, 2026 $159.42M
Sga Expense Q1 2026 · Mar 29, 2025 $177.8M
Net Income Q1 2026 · Mar 28, 2026 −$14.84M
Net Income Q1 2026 · Mar 29, 2025 $25.47M
Operating Income Q1 2026 · Mar 28, 2026 $119.9M
Operating Income Q1 2026 · Mar 29, 2025 $74.67M
Revenue Q1 2026 · Mar 28, 2026 $995.83M
Revenue Q1 2026 · Mar 29, 2025 $984.17M